PortfoliosLab logoPortfoliosLab logo
MDXG vs. CIVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MDXG vs. CIVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MiMedx Group, Inc. (MDXG) and Civitas Resources, Inc. (CIVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


MDXG

1D
0.00%
1M
1.38%
YTD
-45.79%
6M
-47.87%
1Y
-36.83%
3Y*
-17.14%
5Y*
-19.80%
10Y*
-6.98%

CIVI

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

MDXG vs. CIVI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MDXG
MiMedx Group, Inc.
-45.79%-29.63%9.69%215.47%-53.97%-33.48%19.79%323.46%-85.80%42.33%
CIVI
Civitas Resources, Inc.
1.07%-37.07%-27.22%31.55%31.00%159.28%-17.18%12.92%-25.08%-75.76%

Correlation

The correlation between MDXG and CIVI is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (10Y)
Calculated over the trailing 10-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Dec 15, 2011

0.12

The correlation between MDXG and CIVI shifts across timeframes, from -0.04 (1 year) to 0.19 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

MDXG:

$544.80M

CIVI:

$2.44B

EPS

MDXG:

$0.21

CIVI:

$7.03

PE Ratio

MDXG:

17.85

CIVI:

3.90

PEG Ratio

MDXG:

0.00

CIVI:

0.10

PS Ratio

MDXG:

1.41

CIVI:

0.53

PB Ratio

MDXG:

2.24

CIVI:

0.36

Total Revenue (TTM)

MDXG:

$389.42M

CIVI:

$4.71B

Gross Profit (TTM)

MDXG:

$315.59M

CIVI:

$2.06B

EBITDA (TTM)

MDXG:

$53.81M

CIVI:

$3.26B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MDXG vs. CIVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MDXG
MDXG Risk / Return Rank: 1313
Overall Rank
MDXG Sharpe Ratio Rank: 88
Sharpe Ratio Rank
MDXG Sortino Ratio Rank: 99
Sortino Ratio Rank
MDXG Omega Ratio Rank: 1111
Omega Ratio Rank
MDXG Calmar Ratio Rank: 2020
Calmar Ratio Rank
MDXG Martin Ratio Rank: 1717
Martin Ratio Rank

CIVI

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MDXG vs. CIVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MiMedx Group, Inc. (MDXG) and Civitas Resources, Inc. (CIVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MDXGCIVIDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

0.86

Calmar ratioReturn relative to maximum drawdown

-0.60

Martin ratioReturn relative to average drawdown

-1.15

MDXG vs. CIVI - Sharpe Ratio Comparison


Loading charts...

Drawdowns

MDXG vs. CIVI - Drawdown Comparison


Loading charts...

Drawdown Indicators


MDXGCIVIDifference

Max Drawdown

Largest peak-to-trough decline

-93.83%

Max Drawdown (1Y)

Largest decline over 1 year

-61.24%

Max Drawdown (3Y)

Largest decline over 3 years

-68.36%

Max Drawdown (5Y)

Largest decline over 5 years

-83.39%

Max Drawdown (10Y)

Largest decline over 10 years

-93.60%

Current Drawdown

Current decline from peak

-79.57%

Average Drawdown

Average peak-to-trough decline

-53.56%

Ulcer Index

Depth and duration of drawdowns from previous peaks

32.14%

Volatility

MDXG vs. CIVI - Volatility Comparison


Loading charts...

Volatility by Period


MDXGCIVIDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.64%

Volatility (6M)

Calculated over the trailing 6-month period

30.57%

Volatility (1Y)

Calculated over the trailing 1-year period

42.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

61.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

73.95%

Dividends

MDXG vs. CIVI - Dividend Comparison

Neither MDXG nor CIVI has paid dividends to shareholders.


PositionTTM20252024202320222021
CIVI
Civitas Resources, Inc.
3.65%7.38%10.83%11.11%10.85%2.37%
MDXG
MiMedx Group, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%

Financials

MDXG vs. CIVI - Financials Comparison

This section allows you to compare key financial metrics between MiMedx Group, Inc. and Civitas Resources, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B1.20B1.40B20222023202420252026
58.99M
1.17B
(MDXG) Total Revenue
(CIVI) Total Revenue
Values in USD except per share items

MDXG vs. CIVI - Profitability Comparison

The chart below illustrates the profitability comparison between MiMedx Group, Inc. and Civitas Resources, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
70.6%
70.9%
Portfolio components
MDXG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, MiMedx Group, Inc. reported a gross profit of 41.62M and revenue of 58.99M. Therefore, the gross margin over that period was 70.6%.

CIVI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Civitas Resources, Inc. reported a gross profit of 828.00M and revenue of 1.17B. Therefore, the gross margin over that period was 70.9%.

MDXG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, MiMedx Group, Inc. reported an operating income of -16.05M and revenue of 58.99M, resulting in an operating margin of -27.2%.

CIVI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Civitas Resources, Inc. reported an operating income of 778.00M and revenue of 1.17B, resulting in an operating margin of 66.6%.

MDXG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, MiMedx Group, Inc. reported a net income of -10.86M and revenue of 58.99M, resulting in a net margin of -18.4%.

CIVI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Civitas Resources, Inc. reported a net income of 177.00M and revenue of 1.17B, resulting in a net margin of 15.2%.


Frequently Asked Questions


MDXG and CIVI have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for MDXG and CIVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer